In the global arena of biomedicine, Guangzhou's innovative drug companies are rewriting the rules with "hard‑core technology.

Alis Biosciences ("Alis"), an investment fund focused on returning capital to investors that is currently trapped in listed, development-stage biotech companies, today formally launches. Founded by ...

GSK said on Thursday two combination therapies with its cancer drug, Blenrep, have received approval from British authorities ...

The surge in autoimmune diseases, propelled by factors such as genetic predisposition, environmental triggers, and lifestyle changes, underpins the robust growth of the diagnostics market. With ...

Market Overview: The North American autoimmune disease diagnostics market encompasses a wide range of diseases, including rheumatoid arthritis, lupus, multiple sclerosis, and type 1 diabetes. These ...

In the fight against diseases like Alzheimer’s and Parkinson’s, scientists have long struggled to predict how certain ...

Real time quote data is not available at this time. *Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change. **Green ...